Kurt von Emster's Net Worth
$1.62 Million
Who is Kurt von Emster?
Kurt von Emster has an estimated net worth of $1.62 Million. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, CymaBay Therapeutics, Inc., Vaxcyte, Inc., FACET BIOTECH CORP, Vera Therapeutics, Inc., CRISPR Therapeutics AG, Jasper Therapeutics, Inc., and Pernix Sleep, Inc..
SEC CIK
Kurt von Emster's CIK is 0001252524
Past Insider Trading and Trends
2009 was Kurt von Emster's most active year for acquiring shares with 15 total transactions. Kurt von Emster's most active month to acquire stocks was the month of May. 2024 was Kurt von Emster's most active year for disposing of shares, totalling 13 transactions. Kurt von Emster's most active month to dispose stocks was the month of February. 2021 saw Kurt von Emster paying a total of $214,656.25 for 74,753 shares, this is the most they've acquired in one year. In 2010 Kurt von Emster cashed out on 72,554 shares for a total of $1,129,174.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CymaBay Therapeutics, Inc. (CBAY) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -90.00K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
$10.34 | -$170,069.71 | 90K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| -52.07% | -142.38K |
$7.89 | -$1,123,588.45 | 131.04K |
Dec 17 - Dec 18
| |||
Form 4/A
| +6.27% | 1.08K |
$9.13 | -$9.20 | 18.32K |
Jun 5
| |||
Form 4
| -13.75% | -2.92K |
$7.88 | -$23,009.20 | 18.32K |
Jun 5
| |||
Form 4
| -4.66% | -13.35K |
$15.51 | -$207,105.03 | 273.42K |
Scheduled
|
Mar 5
| ||
Form 4
| -19.33% | -68.71K |
$14.49 | -$995,636.88 | 286.77K |
Scheduled
|
Feb 15
| ||
Form 4/A
| -31.44% | -162.98K |
$13.69 | -$2,231,182.51 | 355.48K |
Scheduled
|
Feb 14
| ||
Form 4
| -38.02% | -218.06K |
$15.89 | -$3,464,223.29 | 355.48K |
Scheduled
|
Feb 13 - Feb 14
| ||
Form 4
| +9.62% | 153.85K |
$6.50 | $999,999.00 | 1.75M |
Jul 19
| |||
Form 4
| -8.85% | -40.76K |
$12.35 | -$503,423.05 | 419.69K |
Scheduled
|
Feb 7
| ||
Form 4
| -3.93% | -18.83K |
$12.14 | -$228,608.34 | 460.46K |
Scheduled
|
Feb 5
| ||
Form 4
| -15.82% | -90.10K |
$12.15 | -$1,094,610.70 | 479.29K |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
| -14.64% | -97.64K |
$12.22 | -$1,193,271.58 | 569.38K |
Scheduled
|
Jan 30 - Jan 31
| ||
Form 4
| -5.58% | -39.44K |
$12.18 | -$480,354.84 | 667.02K |
Scheduled
|
Jan 24 - Jan 25
| ||
Form 4
| -16.37% | -138.25K |
$10.40 | -$1,437,831.20 | 706.46K |
Scheduled
|
Jan 22
| ||
Form 4
| -14.58% | -144.22K |
$10.25 | -$1,477,668.72 | 844.72K |
Scheduled
|
Jan 18 - Jan 19
| ||
Form 4
| -0.43% | -4.30K |
$10.21 | -$43,903.00 | 988.93K |
Scheduled
|
Jan 5
| ||
Form 4
| -14.85% | -173.19K |
$9.41 | -$1,629,303.74 | 993.23K |
Scheduled
|
Dec 22
| ||
Form 4
| -4.11% | -50.05K |
$9.26 | -$463,379.42 | 1.17M |
Scheduled
|
Nov 10
| ||
Form 4
| -0.35% | -4.32K |
$9.25 | -$39,979.44 | 1.22M |
Scheduled
|
Nov 1
| ||
Form 4
| -4.63% | -59.21K |
$9.27 | -$548,801.07 | 1.22M |
Scheduled
|
Oct 30 - Oct 31
| ||
Form 4
| -7.84% | -108.88K |
$7.85 | -$854,873.88 | 1.28M |
Oct 2 - Oct 3
| |||
Form 4
| -13.20% | -211.12K |
$8.09 | -$1,707,379.75 | 1.39M |
Sep 28 - Sep 29
| |||
| No matching records found | |||||||||
Vaxcyte, Inc. (PCVX) Snapshot price: $111.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
∞
| 4.17M |
$16.00 |
—
| 4.17M |
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.67K |
$27.00 | -$45,009.00 |
0
|
Apr 21
| |||
Form 4
| -83.33% | -8.33K |
$27.00 | -$224,991.00 | 1.67K |
Apr 20
| |||
Form 4
| +20.00% | 1.67K |
—
|
—
| 10K |
May 26
| |||
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vera Therapeutics, Inc. (VERA) Snapshot price: $37.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.98M |
$11.52 | $214,656.25 | 2.98M |
May 17 - May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.81% | -172.37K |
$20.00 | -$3,447,460.00 | 4.35M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||